Merck & Company, Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Merck & Co., Inc. is a pharmaceutical company that develops medicines and vaccines as well as biologic therapies and animal health products. Merck contributes to treating cancer and diabetes and to vaccinating against HPV and chickenpox.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Merck generates positive Humankind Value on balance. It adds positive value through Healthcare R&D ($311.1 B), Pharmaceuticals ($109.8 B), and Economic Value ($12.5 B). Healthcare is central to our measure of Humankind Value, as a large contribution to modern life expectancies has come from medical innovation in the last 150 years. The company produces economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. Out of the companies we have analyzed, Merck is among the ten most positive contributors to Healthcare R&D and Pharmaceuticals. The value associated with these categories is linked to an estimated 8,734,165.0 additional years lived by people worldwide. Downsides for this company are associated with Greenhouse Gases (-$3.0 B). Healthcare R&D, Pharmaceuticals, Economic Value, and Greenhouse gases are attached to this company as a result of its direct business activities.